We manufactures Ticagrelor. It is an oral antiplatelet drug that is used with low dose aspirin to decrease the risk of myocardial infarction. Call us +91-11-4706 3600. Ticagrelor
Ticagrelor is an oral antiplatelet drug that is used with low dose aspirin to decrease the risk of myocardial infarction and stroke in patients with acute coronary syndromes. Ticagrelor has been linked to rare instances of hypersensitivity reactions accompanied by mild liver injury.Ticagrelor is a triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome. It has a role as a platelet aggregation inhibitor and a P2Y12 receptor antagonist. It is a member of triazolopyrimidines, an organofluorine compound, an aryl sulfide, a secondary amino compound and a hydroxyether.
Kimia Biosciences Ltd™ is engaged in manufacturing of bulk drugs addressing to various high potential therapeutic segments and has envisaged high growth plans through infrastructure creation and CMS. Kimia has earmarked significant investment for this over next two years to become one of the major players in the Indian market. Moving forward towards vertical integration we have plans to set up our own FFF facilities for lifestyle segments with international regulatory standards to be able to not only launch itself in ROW but advance markets as well in future times. We envision becoming the most admired pharmaceutical company in India for clean and ethical business and marketing practices. We believe in maintaining the highest level of integrity, transparency and ethics. We embrace community values and culture and focus on delivering world class solutions at affordable costs. Ticagrelor
Now we are venturing into formulations in near future as well.
Research & Development:
(Approved by Department of Scientific & Industrial Research, (DSIR))
Kimia Biosciences R&D is committed to research and development of improved generic drugs with the goal of addressing unmet patient needs with more meticulous resources and to establish a robust portfolio for a new generation of treatments. Kimia is committed to do significant investments in drug research and development in order to produce effective, safe and affordable medicines.
Infrastructure:
Kimia R&D has well equipped Analytical Lab, synthetic Lab and Intellectual property cell, where each scientist has access to Sci-finder search tools. The Analytical Research lab comprises of HPLC, GC, GC-HS, Auto-Titrator, Polarimeter, UV spectrophotometer, IR spectrophotometer etc. There are dedicated hoods for each scientist in the synthetic lab with Rotavapours, Vacuum & Air dryers, cooling units, mechanical and magnetic stirrers, vacuum systems Instrumentation, scientific and analytical knowledge base at the R&D Centre facilitate:
Impurity profiling for the APIs
Development of Analytical methods and their validations
Specifications from Raw materials to Non-pharmacopoeia Finished products.
Accelerated and Real time stability studies
Location:-974, Aggarwal Millennium Tower II, Netaji Subhash Place, Pitampura, New Delhi-110 034
Contact Number:-91-11-4706 3600
Email:-info@kimiabiosciences.com
Visit us:-http://kimiabiosciences.com/
MitchellJohnson 